Jang GR - Search Results

1

Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis.

Sutjandra L, Rodriguez RD, Doshi S, Ma M, Peterson MC, Jang GR, Chow AT, Pérez-Ruixo JJ. Sutjandra L, et al. Among authors: jang gr. Clin Pharmacokinet. 2011 Dec 1;50(12):793-807. doi: 10.2165/11594240-000000000-00000. Clin Pharmacokinet. 2011. PMID: 22087866

2

Population pharmacokinetic analysis of denosumab in patients with bone metastases from solid tumours.

Gibiansky L, Sutjandra L, Doshi S, Zheng J, Sohn W, Peterson MC, Jang GR, Chow AT, Pérez-Ruixo JJ. Gibiansky L, et al. Among authors: jang gr. Clin Pharmacokinet. 2012 Apr 1;51(4):247-60. doi: 10.2165/11598090-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22420579

3

Denosumab dose selection for patients with bone metastases from solid tumors.

Doshi S, Sutjandra L, Zheng J, Sohn W, Peterson M, Jang G, Chow AT, Pérez-Ruixo JJ. Doshi S, et al. Clin Cancer Res. 2012 May 1;18(9):2648-57. doi: 10.1158/1078-0432.CCR-11-2944. Epub 2012 Mar 6. Clin Cancer Res. 2012. PMID: 22394983

4

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study.

Padhi D, Allison M, Kivitz AJ, Gutierrez MJ, Stouch B, Wang C, Jang G. Padhi D, et al. J Clin Pharmacol. 2014 Feb;54(2):168-78. doi: 10.1002/jcph.239. Epub 2013 Dec 11. J Clin Pharmacol. 2014. PMID: 24272917 Clinical Trial.

5

Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role.

Agoram B, Aoki K, Doshi S, Gegg C, Jang G, Molineux G, Narhi L, Elliott S. Agoram B, et al. J Pharm Sci. 2009 Jun;98(6):2198-211. doi: 10.1002/jps.21578. J Pharm Sci. 2009. PMID: 18837016

6

The pharmacokinetics and pharmacodynamics of denosumab in patients with advanced solid tumours and bone metastases: a systematic review.

Sohn W, Simiens MA, Jaeger K, Hutton S, Jang G. Sohn W, et al. Br J Clin Pharmacol. 2014 Sep;78(3):477-87. doi: 10.1111/bcp.12355. Br J Clin Pharmacol. 2014. PMID: 24548274 Free PMC article. Review.

7

An extended terminal half-life for darbepoetin alfa: results from a single-dose pharmacokinetic study in patients with chronic kidney disease not receiving dialysis.

Padhi D, Ni L, Cooke B, Marino R, Jang G. Padhi D, et al. Clin Pharmacokinet. 2006;45(5):503-10. doi: 10.2165/00003088-200645050-00005. Clin Pharmacokinet. 2006. PMID: 16640455 Clinical Trial.

8

Dietary effects on drug metabolism and transport.

Harris RZ, Jang GR, Tsunoda S. Harris RZ, et al. Among authors: jang gr. Clin Pharmacokinet. 2003;42(13):1071-88. doi: 10.2165/00003088-200342130-00001. Clin Pharmacokinet. 2003. PMID: 14531721 Review.

9

A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis.

Jang G, Kaufman A, Lee E, Hamilton L, Hutton S, Egbuna O, Padhi D. Jang G, et al. Pharmacol Res Perspect. 2014 Apr;2(2):e00033. doi: 10.1002/prp2.33. Epub 2014 Mar 13. Pharmacol Res Perspect. 2014. PMID: 25505582 Free PMC article.

10

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody.

Padhi D, Jang G, Stouch B, Fang L, Posvar E. Padhi D, et al. J Bone Miner Res. 2011 Jan;26(1):19-26. doi: 10.1002/jbmr.173. J Bone Miner Res. 2011. PMID: 20593411 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters